Cite
HARVARD Citation
Richards, H. et al. (2021). Salvage second autologous stem cell transplant for relapsed multiple myeloma in the novel agent era benefits a subset of patients: single-center UK experience. Leukemia & lymphoma. 62 (14), pp. 3544-3547. [Online].